Description: Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs using genetic engineering technology in China. It offers formulations, reagents, and APIs, as well as custom-manufacturing services. The company was founded in 1996 and is based in Xiamen, China.
Home Page: www.amoytop.com
No. 330 Wengjiao Road
Xiamen,
361022
China
Phone:
86 59 2688 9106
Officers
| Name | Title |
|---|---|
| Mr. Li Sun | Chairman & GM |
| Ms. Yiling Yang | Chief Financial Officer |
| Ms. Liping Lai | Director & Deputy GM |
| Mr. Jiehua Zheng | Deputy Gen. Mang. |
| Ms. Meihua Yang | Deputy Gen. Mang. & Core Technician |
| Mr. Zhili Sun | Deputy GM & Sec. of the Board |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 62.9677 |
| Price-to-Book MRQ: | 12.2134 |
| Price-to-Sales TTM: | 10.8748 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1261 |